Literature DB >> 12213972

Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes: effects on oxidative stress.

F Remião1, H Carmo, F Carvalho, M L Bastos.   

Abstract

Sustained high levels of circulating catecholamines may result in cardiotoxicity. Although cardiotoxicity could occur primarily via adrenoceptor activation, there is increasing evidence that it may also occur through oxidative mechanisms. In fact, catecholamines can be converted into aminochromes by auto-oxidation, enzymatically or metal catalyzed, with the concomitant production of reactive intermediates and free radicals. Nevertheless, there is only scarce information concerning the effects of the catecholamine oxidation process on isolated cardiomyocytes. The aim of this work was to evaluate the cardiotoxic effects of isoproterenol (ISO) and its oxidation process in freshly isolated adult rat cardiomyocytes by assessing the cell shape, lactate dehydrogenase leakage, reduced and oxidized glutathione content, and glutathione reductase, peroxidase, and transferase activities. ISO was incubated at concentrations of 0.1, 0.5, and 1 mM in cardiomyocyte suspensions at subphysiological and physiological Ca2+ concentrations for 4 h. The same study was repeated in the presence of 20 microM of Cu2+. The levels of ISO in the incubation medium were monitored throughout the assays. Isoproterenol (1 mM) induced both glutathione oxidation and conjugation, but this effect decreased at subphysiological Ca2+ concentrations. The concomitant incubation with Cu2+ increased ISO oxidation and increased the glutathione oxidation but decreased the extent of glutathione conjugation. Although only a partial ISO oxidation was observed for all studied ISO concentrations in the presence of copper, the underlying oxidative process or its oxidation products, or both, were sufficient to induce a loss of cardiomyocyte viability and a decrease in the glutathione reductase, peroxidase, and transferase activities. Thus, the results suggest that the oxidation of catecholamines could be a major mechanism for catecholamine-induced cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12213972     DOI: 10.1385/ct:1:3:195

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  7 in total

1.  Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.

Authors:  Pavlína Hašková; Hana Jansová; Jan Bureš; Miloslav Macháček; Anna Jirkovská; Katherine J Franz; Petra Kovaříková; Tomáš Šimůnek
Journal:  Toxicology       Date:  2016-10-12       Impact factor: 4.221

Review 2.  Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.

Authors:  Lucas Liaudet; Belinda Calderari; Pal Pacher
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

3.  Investigation of effects of Lacidipine, Ramipril and Valsartan on DNA damage and oxidative stress occurred in acute and chronic periods following isoproterenol-induced myocardial infarct in rats.

Authors:  Mevlut Sait Keles; Yasin Bayir; Halis Suleyman; Zekai Halici
Journal:  Mol Cell Biochem       Date:  2009-03-19       Impact factor: 3.396

4.  Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats.

Authors:  Aman Upaganlawar; Chintan Gandhi; Ramchandran Balaraman
Journal:  Plant Foods Hum Nutr       Date:  2009-03       Impact factor: 3.921

5.  Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats.

Authors:  Arvindkumar E Ghule; Chetan P Kulkarni; Subhash L Bodhankar; Vijaya A Pandit
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

6.  Evaluation of Myocardial Strain Using Cardiac Magnetic Resonance in Patients with Wilson's Disease.

Authors:  Kun Zhang; Ulrike Reuner; Charlotte Hempel; Uwe Speiser; Karim Ibrahim; Frank R Heinzel; Burkert Pieske; Marian Christoph; Felix M Heidrich; Silvio Quick
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

7.  Copper chelation in patients with hypertrophic cardiomyopathy.

Authors:  Anna Reid; Christopher Miller; John Peter Farrant; Rahul Polturi; David Clark; Simon Ray; Garth Cooper; Matthias Schmitt
Journal:  Open Heart       Date:  2022-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.